Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001415889-25-021834
Filing Date
2025-08-14
Accepted
2025-08-14 16:13:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11431
  Complete submission text file 0001415889-25-021834.txt   13025
Mailing Address 50 RUE DE DIJON DAIX I0 21121
Business Address 50 RUE DE DIJON DAIX I0 21121 33380447500
Inventiva S.A. (Subject) CIK: 0001756594 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91576 | Film No.: 251219191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 374 RUE SAINT ST HONORE PARIS I0 75001
Business Address 374 RUE SAINT ST HONORE PARIS I0 75001 33-1-85-73-6603
Andera Partners (Filed by) CIK: 0001757283 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A